3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Breast
1
Conditions
Colorectal Neoplasms
8
Breast Neoplasms
7
Polycythemia Vera
5
Venous Thromboembolism
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Tobacco Use Disorder
2
Thrombocythemia, Essential
2
Smoking Cessation
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lung Neoplasms
2
Barrett Esophagus
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Tuberous Sclerosis
1
Thromboembolism
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Seizures
1
Salivary Gland Neoplasms
1
Recurrence
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Interventions
cabazitaxel
3
Trastuzumab
3
Cyclophosphamide
2
Cetuximab
2
Carboplatin
2
Aspirin
2
ribociclib
1
pertuzumab
1
eribulin
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Liquid Biopsy
1
Letrozole
1
Ipilimumab
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Gemcitabine
1
Fulvestrant
1
Epirubicin
1
Docetaxel
1
Denosumab
1
Circulating Tumor DNA
1
Cell-Free Nucleic Acids
1
CA-72-4 antigen
1
CA-19-9 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplastic Cells, Circulating
×
Aspirin
×
Clear all
NCT05637567
2023-11-13
ASAP
German Cancer Research Center
Phase 2
Not yet recruiting
170 enrolled
NCT02602938
2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2
Unknown
40 enrolled